BPPV, history of gout associated with Ménière's disease

Published Date: 02 Mar 2023

According to a study published online Dec. 26 in the Journal of Clinical Medicine, a history of gout is associated with an increased risk of benign paroxysmal positional vertigo (BPPV) and Ménière's disease.

Read Full News

Latest News

Tumor Genomic Testing: Too Little, Too Late

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-Impact Exercise Linked to Anal Incontinence in Women

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre's Inflammatory Bowel Drug Shown to Reduce Disease Activity in Mid-stage Study

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Age and Visceral Fat May Trend Together: What to Know

Why fat that surrounds organs is more dangerous continues to be studied.

Vaccination Protects Young Men From HPV-Related Cancers

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Why fat that surrounds organs is more dangerous continues to be studied.

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

Emerging research is showing more and more connection between the two.

News All Time

IUS May Guide Treatment in Children With Ulcerative Colitis

Intestinal ultrasound scan may serve as an early non-invasive predictor of corticosteroid resistance and short-term colectomy in children with acute severe ulcerative colitis.

Routine EHR Data May Help Predict Pancreatic Cancer Risk

A risk model that uses routine clinical data can identify people at high risk of developing pancreatic cancer over the next 3 years.

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Analysis-Pediatricians Win Round 1 in Vaccine Fight, but Damage Has Been Done

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

From Royal Courts to Clinics: How Enemas Evolved

Once considered a universal remedy, enemas are now used selectively for specific clinical indications, such as bowel preparation.

Duchenne Gene Therapy Shows Improved Muscle Function in Trial

Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy ⁠in patients with Duchenne muscular dystrophy showed continued...

Early Top-Down Therapy Cuts Surgery Risk in Crohn’s

Five-year PROFILE follow-up shows early top-down infliximab-based therapy markedly reduces abdominal surgery and hospitalizations in Crohn’s vs step-up escalation.

Commercial Microbiome Tests: Unreliable Results

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

AI Beats Conventional Endoscopy in Neoplasm Detection

AI-assisted esophagogastroduodenoscopy is more effective than the conventional procedure in detecting upper GI neoplasms, particularly for lesions measuring ≤ 10 mm.

Global Study Supports Meat-Free Diets for Cancer Prevention

Observational data on more than 1.8 million people did yield surprises when it came to colorectal and esophageal cancers.

Healthy Midlife Diet Tied to Lower Risk of Cognitive Decline

Greater adherence to the DASH diet and other healthy eating patterns — especially in midlife — is linked to lower risk of cognitive decline later in life, three major US studies show.

Recommended News For You

Updates from the 2022 WHO classification of kidney epithelial tumors

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

Recommended Articles For You

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study confirms link between breast density, higher breast cancer risk

2.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

3.

How a California Oncologist Making $850k Spends Money

4.

Data indicate 1 in 3 US adults unaware of connection between HPV and cancers

5.

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

1.

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment

2.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

3.

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments

4.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

5.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot